Medline Inc.
Medline Inc. (MDLN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDLN · as of Jun 8, 2026
Key Statistics
Explore Medline Inc. Data
mdln stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 85.7%
The MDLN analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $48.55, representing +44.45% upside from the current price of $33.61.
Competitors & Peers
mdln competitorsMDLN
AVTR
BLCO
BRCB
COO
INFUStock Performance
Full HistoryAbout Medline Inc.
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It…
what is medline inc. · mdln stock overview · medline inc. company profile · who is medline inc. ceo · mdln NASDAQ · medline inc. headquarters · medline inc. business segments
About Stock Overview & Key Data
Medline Inc. (MDLN) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Dec 17, 2025. As of the latest trading session, MDLN stock price is $33.61, with a market capitalization of $28.4B. The stock has returned -18.02% over the past 12 months and -19.98% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Medline Inc. stock is Buy, with an average 12-month price target of $48.55. In fiscal year 2025, Medline Inc. reported revenue of $28.4B and net income of $1.2B. For detailed data — including Medline Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Medline Inc. (MDLN) stock price is $33.61. The stock is traded on NASDAQ under the ticker symbol MDLN. The 52-week range is $32.81 – $50.88.